{
  "Variants Include": [
    {
      "Gene": "PINK1",
      "variants": [
        {
          "HGVS": "NM_017617.3:c.1309C>T",
          "cDNA Change": {
            "transcript": "NM_017617.3",
            "ref": "C",
            "alt": "T",
            "position": "1309"
          },
          "Protein Change": {
            "ref": "W",
            "alt": "*",
            "position": "437"
          },
          "Description in input context": "homozygous W437X nonsense mutation"
        }
      ]
    }
  ],
  "Described Disease": {
    "Described Disease": "Parkinson disease",
    "MONDO": "MONDO:0005312"
  },
  "Experiment Method": [
    {
      "Assay Method": "Mitochondrial Respiratory Function Analysis",
      "Material used": {
        "Material Source": "Fibroblasts",
        "Material Name": "Patient and control fibroblasts",
        "Description": "Comparison between fibroblasts from patient with PINK1 mutation and normal controls."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_017617.3:c.1309C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "Patient fibroblasts showed reduced respiratory activity, lower respiratory control ratio, and increased reliance on glycolytic production compared to controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal respiratory activity and control ratio in control fibroblasts.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Reduced respiratory activity and control ratio in patient fibroblasts.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Oxidative Phosphorylation Complex Quantification",
      "Material used": {
        "Material Source": "Fibroblasts",
        "Material Name": "Patient and control fibroblasts",
        "Description": "Quantification of oxidative phosphorylation complex quantity and activity."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_017617.3:c.1309C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "Patient fibroblasts showed reduced quantity and activity of oxidative phosphorylation complexes compared to controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal quantity and activity of oxidative phosphorylation complexes in control fibroblasts.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Reduced quantity and activity of oxidative phosphorylation complexes in patient fibroblasts.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cytochrome c Content Measurement",
      "Material used": {
        "Material Source": "Fibroblasts",
        "Material Name": "Patient and control fibroblasts",
        "Description": "Measurement of cytochrome c content in fibroblasts."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_017617.3:c.1309C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "Patient fibroblasts showed reduced cytochrome c content compared to controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal cytochrome c content in control fibroblasts.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Reduced cytochrome c content in patient fibroblasts.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    },
    {
      "Assay Method": "Cytochrome c Oxidase Activity Measurement",
      "Material used": {
        "Material Source": "Fibroblasts",
        "Material Name": "Patient and control fibroblasts",
        "Description": "Measurement of cytochrome c oxidase activity in fibroblasts."
      },
      "Readout type": "Quantitative",
      "Readout description": [
        {
          "Variant": "NM_017617.3:c.1309C>T",
          "Conclusion": "Abnormal",
          "Molecular Effect": "loss-of-function",
          "Result Description": "Patient fibroblasts showed reduced cytochrome c oxidase activity compared to controls."
        }
      ],
      "Biological replicates": {
        "Biological replicates": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Technical replicates": {
        "Technical replicates": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Basic positive control": {
        "Basic positive control": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Basic negative control": {
        "Basic negative control": "N.D.",
        "Description": "Not explicitly mentioned in the abstract."
      },
      "Validation controls P/LP": {
        "Validation controls P/LP": "N.D.",
        "Counts": "N.D."
      },
      "Validation controls B/LB": {
        "Validation controls B/LB": "N.D.",
        "Counts": "N.D."
      },
      "Statistical analysis method": {
        "Statistical analysis method": "N.D."
      },
      "Threshold for normal readout": {
        "Threshold for normal readout": "Normal cytochrome c oxidase activity in control fibroblasts.",
        "Source": "Literature"
      },
      "Threshold for abnormal readout": {
        "Threshold for abnormal readout": "Reduced cytochrome c oxidase activity in patient fibroblasts.",
        "Source": "Literature"
      },
      "Approved assay": {
        "Approved assay": "Yes"
      }
    }
  ]
}